It is my understanding, which could always be incorrect of course, that 8% of diabetics die from hypo event in their lifetime. This obviously is still VERY HIGH.
Honest mistake I am sure. I believe what he/she meant is that 8% of diabetics die from hypo in their lifetime. This is WAY TOO MUCH.
But..... we are just moving with the index today. Nothing better nothing worse. Given the lackluster scripts this tells me that 'we' are a pretty dedicated and hardcore group of retail investors that are not going to sell on a whim and 'we' all are taking a long view.
Personally I have a three year window and I'm holding until then come ### or high water. The science and the product is what got me here, and I hope in the end it will carry the day, because it appears its going to have to.
Good luck to all longs.
50 and 200 day moving average is 5.00 I ask you who's money is dead? The shorts are getting impatient too.
Her feedback holds a lot of weight with me too! She is objective and only has diabetics in mind. She is not invested in MNKD.
Yes Im not saying that I think there will be one either. Its just not totally out of the question for SNY to have a booth with video.
In fact I can say without a doubt that my company did in fact have a video at its booth. It wasn't a promotional video for a specific product but a video outlining our commitment in a specific area of focus.
I've read maybe one of his poorly articulated broken English articles, and to be honest I don't think I was able to get all the way through that one. IMHO he is in the same boat with Sierra World.
Really?? Dr. Tran the stock trader? LMAO Obviously he's an excellent Dr.
No guarantees of success of course but yes I am holding! By my way of thinking we have almost unlimited upside potential from this level and at the absolute worst a 50% decrease on the downside. The downside (I don't believe will happen) will be temporary if ever.
I have said this before and Ill say it once more. With 28 days to cover (highest I have ever seen for any stock) why doesn't a MM with deep pockets put on some buying pressure and force a short squeeze? It would seem that a large call purchase followed by a sustained frontal assault of buying on the backside would manufacture a short squeeze?
Maybe its in the works already and they are just waiting for a small spark to set it into motion (good script numbers, EU Filing, South American approval, Techno agreement?) This is a dirty game, and shorts are not afraid to pass FUD to help their position. Why not start a juicy buy-out rumor and manufacture a spark?
Anyway this thing seems to be inflated beyond the breaking point. This should be an interesting month. Good luck to all longs.
Disclaimer: I am a scientist not an economist so take this post with a grain of salt. ;)
I have said this multiple times.
All just my opinion
1). Sales can be linear or parabolic. Nice increase in re-fills is a tentative good sign.
2). Controlled launch has nothing to do with manufacturing capacity
3). Phase II launch in type I was pending Toujeo approval
4). Phase II lainch in type II is still pending 12u cartrige approval.
5). I never expected rapid uptake and believed that we would test high 4.00's
I appreciate your input and value real opinions on this board. Good luck to all longs.
It's a conflict of business interest for lilly and novo that they didn't have the foresight to partner with a company offering what will become the highest selling pharmaceutical of all time! ;)
If what this guy is saying is in fact true then Als prediction will I'm fact be true
To me that says something about a bottom forming a strong base here.
Yes good stuff!
They would want to tie it to Toujeo obviously? Regarding TII as I said they are trying to expand the insulin TII market not erode it. Early adopters of insulin through afrezza will take away market share from orals not Toujeo.
If by some chance Afreeza actually halts disease progression leading to patients not needing basal, how on earth is that even remotely a bad outcome for SNY? If that's the case they will own the ENTIRE TII market.
Best post I have seen here all year!!! Thank you so much for posting again! I was unaware the a super-stable insulin has already been developed! That is fantastic news! As indicated by your post the molecular weight does fall with-in the limits of technosphere albumin + insulin= 71.8 kDa
"Drugs ranging in molecular weight from 300 to 100,000 Da are absorbed readily. Drugs having molecular weights 100,000 Da can be formulated for local lung delivery, but their systemic absorption is limited by their large molecular size."
As indicated by OPC this may not be licensed to SNY but that would seem to be a much smaller hurdle that developing the technology. Exciting news! My apologies fofo for poo pooing your post.
There is no conflict!!! With or without Afrezza they were going to have to convince people to switch to Toujeo. How is that a conflict? Either Toujeo has attributes that justify switching or it doesn't. Afrezza has nothing to do with that.
IMHO the lower incidence of hypo's with Toujeo combined with the same attributes for Afrezza will ultimately be its selling point.
Regarding TII they are going after early adopters with will grow the TII insulin market not erode it. IMHO there is no conflict.
I agree with you 100%. I have been saying for some time the the ENTIRE reason for the soft launch is to transition TI to Afrezza + Toujeo, and that the Toujeo approval is actually good news for Afrezza.
The second factor in the soft launch is the 12U cartridge for TII. TII's require ALOT more insulin and they NEED the 12U cartridge for convenience. Its not convenient to have to use 3-5 cartridges per meal. Once 12U cartridge is approved we will see a strong push in the TII market.
Manufacturing capacity being the reasons behind the controlled launch is simply wrong. IMHO